Guide to bone health and disease in cystic fibrosis

Robert M Aris1, Peter A Merkel, Laura K Bachrach

  • 1CB 7020, 4131 Bioinformatics, University of North Carolina, Chapel Hill, North Carolina 27599-7524, USA. aris@med.unc.edu

Insights

Cystic fibrosis (CF) patients face significant bone disease risks, including low bone density and fractures. Addressing multiple risk factors is crucial for managing bone health in adults with CF.

Area of Science:

  • Bone biology and genetics
  • Pulmonary medicine
  • Endocrinology

Background:

  • Cystic fibrosis (CF) is a prevalent genetic disorder primarily affecting Caucasian populations, leading to respiratory failure.
  • Increased lifespan in CF patients has revealed bone disease as a common complication, with 50-75% of adults experiencing low bone density and fractures.
  • The rising number of adult CF survivors necessitates a focus on managing chronic complications like bone disease.

Framework:

  • This review summarizes the Cystic Fibrosis Foundation's 2002 consensus conference on CF-related bone disease.
  • It addresses the pathogenesis, diagnosis, and treatment of bone complications in cystic fibrosis.
  • The goal was to establish practice guidelines for optimizing bone health in CF patients.

Implementation:

  • Key risk factors for poor bone health in CF include pancreatic insufficiency affecting vitamin absorption, hormonal imbalances, chronic infections, physical inactivity, and corticosteroid use.
  • Effective management requires a multifactorial approach targeting these specific risk factors.
  • Early diagnosis and intervention are vital for preventing fractures and improving long-term outcomes.

Implications:

  • Optimizing bone health is critical for the quality of life and long-term survival of individuals with cystic fibrosis.
  • Developing and implementing evidence-based guidelines can significantly reduce the burden of bone disease in CF.
  • Further research into the complex interplay of factors affecting bone metabolism in CF is warranted.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
What is the Skeletal System?01:02

What is the Skeletal System?

Overview
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...